GC Corp.
CIK: 0001931382
GC Corp.'s purchase track record
GC Corp. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/11/2026 | ARTV | $16.50M | +5.9% | pending | — |
| 7/22/2024 | ARTV | $25.00M | -11.0% | -39.9% | +8.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ARTV | ▲ Buy | Open Market | 1,085,069 | $12.5M | 5/11/2026 | View on chart |
| ARTV | ▲ Buy | Open Market | 347,222 | $4.0M | 5/11/2026 | View on chart |
| ARTV | ▼ Sell | Other | 667,185 | — | 7/22/2024 | View on chart |
| ARTV | ▼ Sell | Other | 330,095 | — | 7/22/2024 | View on chart |
| ARTV | ▼ Sell | Other | 294,117 | $3.0M | 7/22/2024 | View on chart |
| ARTV | ▲ Buy | Open Market | 1,666,666 | $20.0M | 7/22/2024 | View on chart |
| ARTV | ▼ Sell | Other | 292,791 | — | 7/22/2024 | View on chart |
| ARTV | ▼ Sell | Other | 62,181 | — | 7/22/2024 | View on chart |
| ARTV | ▼ Sell | Other | 256,316 | $2.6M | 7/22/2024 | View on chart |
| ARTV | ▲ Buy | Open Market | 416,666 | $5.0M | 7/22/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
ARTV Announces Oral Presentation of AlloNK Data at Sjögren’s Symposium
Artiva Biotherapeutics will give an oral presentation of its AlloNK® clinical data at the 17th International Symposium on Sjögren’s Disease. The talk focuses on early results from a study in patients with this autoimmune disorder. The data could influence how investors view the company’s therapeutic pipeline. The presentation is a milestone before any formal publication or regulatory filing.
ARTV Announces Oral Presentation of AlloNK Data at Sjögren’s Symposium. Artiva Biotherapeutics will give an oral presentation of its AlloNK® clinical data at the 17th International Symposium on Sjögren’s Disease. The talk focuses on early results from a study in patients with this autoimmune disorder. The data could influence how investors view the company’s therapeutic pipeline. The presentation is a milestone before any formal publication or regulatory filing.